Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2024-02-15 00:00:00 ET · period of report 2024-02-13 · accession 0001104659-24-024605 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-15 | 2024-02-13+ | RYTM | Shulman Joseph | Chief Technical Off | S - Sale | $50.00 | -2,954 | 1,119 | -73% | -$147.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-14 | S | D | 1,089 | $50.01 | 30 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-13 | S | D | 1,865 | $50.00 | 1,119 | D | — | — |